Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3SJB9
|
|||
| Drug Name |
E2023
|
|||
| Synonyms |
Lorcaserin
Click to Show/Hide
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Dravet syndrome [ICD-11: 8A61.11] | Phase 3 | [1] | |
| Company |
Eisai
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04572243) A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study With Open-Label Extension Phase of Lorcaserin as Adjunctive Treatment in Subjects With Dravet Syndrome. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.